1834 Investment Advisors’s Invesco BulletShares 2021 High Yield Corporate Bond ETF BSJL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-500
Closed -$12K 534
2021
Q2
$12K Hold
500
﹤0.01% 405
2021
Q1
$12K Hold
500
﹤0.01% 372
2020
Q4
$12K Hold
500
﹤0.01% 360
2020
Q3
$11K Hold
500
﹤0.01% 336
2020
Q2
$11K Sell
500
-7,400
-94% -$167K ﹤0.01% 323
2020
Q1
$175K Hold
7,900
0.03% 187
2019
Q4
$195K Hold
7,900
0.03% 198
2019
Q3
$194K Sell
7,900
-860
-10% -$21.2K 0.03% 206
2019
Q2
$216K Hold
8,760
0.03% 184
2019
Q1
$216K Buy
8,760
+500
+6% +$12.3K 0.03% 190
2018
Q4
$195K Buy
8,260
+560
+7% +$13.6K 0.03% 178
2018
Q3
$191K Hold
7,700
0.03% 196
2018
Q2
$189K Buy
+7,700
New +$190K 0.03% 183
2018
Q1
Sell
-7,800
Closed -$195K 485
2017
Q4
$195K Buy
+7,800
New +$196K 0.03% 173

Other funds holding BSJL

1834 Investment Advisors's BSJL Position: Q3 2021 in Review

1834 Investment Advisors sold out of Invesco BulletShares 2021 High Yield Corporate Bond ETF (BSJL) in Q3 2021, closing a stake of 500 shares — an estimated $12K sold.

1834 Investment Advisors first reported a position in BSJL in Q4 2017 and held it in 14 quarters. The position peaked at $216K in Q2 2019. 110 funds tracked by Wall St. Rank hold BSJL as of Q3 2021.

  • 1834 Investment Advisors reported no remaining Invesco BulletShares 2021 High Yield Corporate Bond ETF position as of Q3 2021 after selling out during the quarter.
  • 1834 Investment Advisors sold 500 Invesco BulletShares 2021 High Yield Corporate Bond ETF shares in Q3 2021, an estimated $12K.
  • 1834 Investment Advisors first reported a position in Invesco BulletShares 2021 High Yield Corporate Bond ETF in Q4 2017 and held it in 14 quarters.
  • 1834 Investment Advisors's Invesco BulletShares 2021 High Yield Corporate Bond ETF position peaked at $216K in Q2 2019.
  • 110 funds tracked by Wall St. Rank held Invesco BulletShares 2021 High Yield Corporate Bond ETF as of Q3 2021.

Based on 1834 Investment Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.